ATYR PHARMA INC (LIFE)

US0021202025 - Common Stock

1.6  +0.03 (+1.91%)

After market: 1.5992 0 (-0.05%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
353.00K10.39M0.0010.46M420.00K
Minority Interest Expense
8.00K10.00K10.00K10.00K160.00K
Operating Expenses
55.27M56.79M34.02M26.37M23.40M
Research and Development
42.29M42.81M23.26M17.29M14.05M
Selling, General, and Administrative Expenses
12.98M13.98M10.75M9.08M9.35M
Operating Income
-54.92M-46.40M-34.02M-15.91M-22.98M
Interest Income/Expense
N/AN/AN/AN/AN/A
Other Income/Expense
4.52M1.06M240.00K-320.00K-790.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-50.40M-45.34M-33.78M-16.23M-23.76M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-50.39M-45.34M-33.77M-16.22M-23.60M
EBITDA
-54.33M-46.17M-33.54M-15.34M-22.34M
 
Per Share Data
EPS Diluted Total Ops
-0.94-1.60-1.77-1.77-7.03
Non GAAP EPS
-0.96-1.60-1.88-1.59-7.33
 
Statistics
Profit Margin
-14274.50%-436.38%N/A-155.07%-5619.05%
Operating Profit Margin
-15557.79%-446.58%N/A-152.10%-5471.43%

All data in USD

Charts